INVVAX INC
2 known investors
InvVax is developing a universal influenza vaccine based on its own vaccine technology. The company focuses on biotechnology and vaccine research and commercialization.
Founders & leadership
AY
Arthur YounginFounder
Investors · 2
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2022 | $255.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does INVVAX INC do?
- InvVax is developing a universal influenza vaccine based on its own vaccine technology. The company focuses on biotechnology and vaccine research and commercialization.
- Who are INVVAX INC's investors?
- INVVAX INC's investors include Evolution VC Partners, Sand Hill Angels.